Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model

Epstein–Barr virus (EBV) was the first human virus proved to be closely associated with tumor development, such as lymphoma, nasopharyngeal carcinoma, and EBV-associated gastric carcinoma. Despite many efforts to develop prophylactic vaccines against EBV infection and diseases, no candidates have su...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Bingchun, Zhang, Xiao, Krummenacher, Claude, Song, Shuo, Gao, Ling, Zhang, Haojiong, Xu, Miao, Feng, Lin, Feng, Qisheng, Zeng, Musheng, Xu, Yuting, Zeng, Yixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938345/
https://www.ncbi.nlm.nih.gov/pubmed/29765376
http://dx.doi.org/10.3389/fimmu.2018.00932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938345/
https://www.ncbi.nlm.nih.gov/pubmed/29765376
http://dx.doi.org/10.3389/fimmu.2018.00932

Ejemplares similares